Remove Business Remove Compliance Remove DEA
article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. Mr. Feldmann is a trusted advisor for marijuana businesses.

DEA 113
article thumbnail

From DEA to Legal Cannabis: Charles Feldmann Weighs In

CannaTech

a managing partner at Denver-headquartered Feldmann Nagel Cantafio Margulis Gonnell PLLC, where he serves as an adviser to the cannabis industry’s largest and most profitable businesses. As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs.

DEA 80
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Charles Feldmann to Speak at Canna Tech Global

MJ Business Attorneys

Charles Feldmann, a former DEA Drug Task Force Commander and former state’s narcotics prosecutor, will be sharing his insight and expertise on the other side of the cannabis constitutional law. Our Denver marijuana business lawyers can assist you, regardless of the complexity of your case. to speak to a member from our firm.

DEA 100
article thumbnail

Marijuana Mayhem

MJ Business Attorneys

Fighting Investment Fraud in the Marijuana Business Industry. with defrauding investors about returns in cannabis businesses after Greenview used misleading marketing materials to raise over $3 million from investors. This is not the first SEC effort against investor fraud in the marijuana business industry.

Marijuana 100
article thumbnail

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

Cannabis Law Report

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and other psychoactive substances, and manufactures multiple commercial Cannabidiol (CBD) products in compliance with the 2018 U.S. OXNARD, Calif.–(BUSINESS

article thumbnail

Navigating regulations in the hemp industry June 22

Cannabis Law Report

Hemp Roundtable, alongside the Minority Cannabis Business Association, hosts Navigating Regulations in the Hemp Industry: A complimentary webinar for small and minority-owned hemp companies tomorrow, June 22, 2021, 2-3PM EDT. FDA, USDA, DEA basics. Future projections for compliance. Tomorrow, the U.S. Useful resources.

Hemp 71
article thumbnail

The Supreme Court Puts a Halt to a Commandeering Congress

MJ Business Attorneys

Attorney Charles Feldmann—former DEA Task Force Commander himself—understands government policy and utilizes his background to help his clients in the marijuana industry achieve and maintain strict compliance with state and federal regulations.

Policy 100